Ally Bridge Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-143,479	Closed	-$8.66M	–	28
2023 Q4	$8.66M	Sell	143,479 -39,626	-22%	-$2.39M	5.16%	9
2023 Q3	$10.4M	Buy	183,105 +91,692	+100%	+$5.23M	12.25%	1
2023 Q2	$4.66M	Buy	91,413 +18,563	+25%	+$947K	5.65%	8
2023 Q1	$1.56M	Buy	+72,850	New	+$1.56M	2.04%	14